No Relief In Sight For Future Of OTC Asthma Products
This article was originally published in The Pink Sheet Daily
Executive Summary
CDER points out epinephrine inhalers are the only OTC meter-dosed inhalers for treating asthma. The products' removal from the market in 16 months raises questions about whether FDA would approve another nonprescription asthma drug.